Bone Marrow Failure in Fanconi Anemia Is Triggered by an Exacerbated p53/p21 DNA Damage Response that Impairs Hematopoietic Stem and Progenitor Cells

被引:251
|
作者
Ceccaldi, Raphael [1 ,2 ,3 ,4 ]
Parmar, Kalindi [10 ]
Mouly, Enguerran [1 ]
Delord, Marc [1 ]
Kim, Jung Min [10 ]
Regairaz, Marie [1 ,2 ,3 ]
Pla, Marika [1 ,5 ]
Vasquez, Nadia [4 ]
Zhang, Qing-Shuo [11 ]
Pondarre, Corinne [12 ]
de Latour, Regis Peffault [6 ]
Gluckman, Eliane [6 ]
Cavazzana-Calvo, Marina [13 ]
Leblanc, Thierry [14 ]
Larghero, Jerome [1 ,5 ,8 ,9 ]
Grompe, Markus [11 ]
Socie, Gerard [1 ,6 ,7 ]
D'Andrea, Alan D. [10 ]
Soulier, Jean [1 ,2 ,3 ,4 ]
机构
[1] Univ Paris Diderot, Sorbonne Paris Cite, Inst Hematol IUH, Paris 75010, France
[2] St Louis Hosp, INSERM, U944, F-75010 Paris, France
[3] St Louis Hosp, CNRS, UMR7212, F-75010 Paris, France
[4] St Louis Hosp, APHP, Hematol Lab, F-75010 Paris, France
[5] St Louis Hosp, INSERM, UMRS 940, F-75010 Paris, France
[6] St Louis Hosp, APHP, Hematol Transplantat Dept, F-75010 Paris, France
[7] St Louis Hosp, INSERM, U728, F-75010 Paris, France
[8] St Louis Hosp, APHP, Cell Therapy Unit, F-75010 Paris, France
[9] St Louis Hosp, APHP, CIC BT501, F-75010 Paris, France
[10] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA
[11] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97239 USA
[12] Hosp Civils Lyon, Inst Pediat Hematol & Oncol, F-69008 Lyon, France
[13] Hop Necker Enfants Malad, INSERM, U768, F-75015 Paris, France
[14] Robert Debre Hosp, Dept Pediat Hematol, F-75019 Paris, France
基金
美国国家卫生研究院;
关键词
TNF-ALPHA; P53; CANCER; REPAIR; PATHWAY; SENESCENCE; FANCD2; DEFICIENCY; CHECKPOINT; COOPERATE;
D O I
10.1016/j.stem.2012.05.013
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Fanconi anemia (FA) is an inherited DNA repair deficiency syndrome. FA patients undergo progressive bone marrow failure (BMF) during childhood, which frequently requires allogeneic hematopoietic stem cell transplantation. The pathogenesis of this BMF has been elusive to date. Here we found that FA patients exhibit a profound defect in hematopoietic stem and progenitor cells (HSPCs) that is present before the onset of clinical BMF. In response to replicative stress and unresolved DNA damage, p53 is hyperactivated in FA cells and triggers a late p21(Cdkn1a)-dependent G0/G1 cell-cycle arrest. Knockdown of p53 rescued the HSPC defects observed in several in vitro and in vivo models, including human FA or FA-like cells. Taken together, our results identify an exacerbated p53/p21 "physiological" response to cellular stress and DNA damage accumulation as a central mechanism for progressive HSPC elimination in FA patients, and have implications for clinical care.
引用
收藏
页码:36 / 49
页数:14
相关论文
共 50 条
  • [1] p53 and p21 expression in bone marrow clots of megaloblastic anemia patients
    Kwan, Denis Nicolas
    Queiroz Rocha, Julia Thalita
    Niero-Melo, Ligia
    Custodio Domingues, Maria Aparecida
    Oliveira, Cristiano Claudino
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (07): : 1829 - 1833
  • [2] The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation
    Du, Wei
    Amarachintha, Surya
    Erden, Ozlem
    Wilson, Andrew
    Pang, Qishen
    ONCOTARGET, 2016, 7 (37) : 60005 - 60020
  • [3] Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway
    Gu, Zhifeng
    Tan, Wei
    Feng, Guijuan
    Meng, Yan
    Shen, Biyu
    Liu, Hong
    Cheng, Chun
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 387 (1-2) : 27 - 37
  • [4] p53 binding to the p21 promoter is dependent on the nature of DNA damage
    Hill, Richard
    Bodzak, Ewelina
    Blough, Michael D.
    Lee, Patrick W. K.
    CELL CYCLE, 2008, 7 (16) : 2535 - 2543
  • [5] Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression
    MacKenzie Ross, Alastair D.
    Cook, Martin G.
    Chong, Heung
    Hossain, Mehnaz
    Pandha, Hardev S.
    Bennett, Dorothy C.
    PIGMENT CELL & MELANOMA RESEARCH, 2013, 26 (02) : 226 - 235
  • [6] Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes
    Fei, Chengming
    Zhao, Youshan
    Guo, Juan
    Gu, Shucheng
    Li, Xiao
    Chang, Chunkang
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (06) : 476 - 486
  • [7] The HDAC inhibitor depsipeptide transactivates the p53/p21 pathway by inducing DNA damage
    Wang, Haiying
    Zhou, Wen
    Zheng, Zhixing
    Zhang, Ping
    Tu, Bo
    He, Qihua
    Zhu, Wei-Guo
    DNA REPAIR, 2012, 11 (02) : 146 - 156
  • [8] DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions
    Insinga, Alessandra
    Cicalese, Angelo
    Faretta, Mario
    Gallo, Barbara
    Albano, Luisa
    Ronzoni, Simona
    Furia, Laura
    Viale, Andrea
    Pelicci, Pier Giuseppe
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (10) : 3931 - 3936
  • [9] The p53/p21 DNA damage-signaling pathway is defective in most meningioma cells
    Al-Khalaf, Huda H.
    Lach, Boleslaw
    Allam, Ayman
    AlKhani, Ahmed
    Alrokayan, Salman A.
    Aboussekhra, Abdelilah
    JOURNAL OF NEURO-ONCOLOGY, 2007, 83 (01) : 9 - 15
  • [10] The p53/p21 DNA damage-signaling pathway is defective in most meningioma cells
    Huda H. Al-Khalaf
    Boleslaw Lach
    Ayman Allam
    Ahmed AlKhani
    Salman A. Alrokayan
    Abdelilah Aboussekhra
    Journal of Neuro-Oncology, 2007, 83 : 9 - 15